Overview

Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

Status:
Terminated
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of treatment with 0.017% P-321 on Dry Eye Symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
Parion Sciences
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions